兵庫県立姫路循環器病センターは、兵庫県姫路市にあった県立病院。1981年に日本で初めての循環器専門の自治体病院として開設され、当初より心臓血管病と脳血管障害を二本柱とした診療を行っていた。臨床研修病院の指定を受けるほか、兵庫県災害拠点病院、救急告示医療機関などの指定を受けていた。

During the past decade, Hyogo Brain and Heart Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hyogo Brain and Heart Center" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hyogo Brain and Heart Center" are "Heart Failure" (2 trials), "Atrial Fibrillation" (1 trials), "Myocardial Infarction" (1 trials) and "Percutaneous Coronary Intervention" (1 trials). Many other conditions were trialed in "Hyogo Brain and Heart Center" in a lesser frequency.

Most popular intervention types in "Hyogo Brain and Heart Center" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Empagliflozin" (3 trials), "Placebo" (3 trials), "Aspirin" (1 trials), "Clopidogrel or Ticagrelor" (1 trials) and "Dabigatran Etexilate 110mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hyogo Brain and Heart Center" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Hyogo Brain and Heart Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hyogo Brain and Heart Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hyogo Brain and Heart Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".